首页 > 市场调查报告书 > 医疗设备

生技设备

次世代定序(NGS) 自动化市场规模、份额和成长分析（按产品类型、应用、定序类型、最终用户和地区划分）—产业预测（2026-2033 年）

市场调查报告书

商品编码

1897612

次世代定序(NGS) 自动化市场规模、份额和成长分析（按产品类型、应用、定序类型、最终用户和地区划分）—产业预测（2026-2033 年）

NGS Automation Market Size, Share, and Growth Analysis, By Product (Workstation/Robotic Platform, Reagents & Consumables), By Application (Drug Discovery, Clinical Diagnostics), By Sequencing Type, By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月23日 | 出版商:

SkyQuest | 英文 242 Pages | 商品交期: 3-5个工作天内

价格

简介目录

全球次世代定序(NGS) 自动化市场规模预计在 2024 年达到 45 万美元，在 2025 年成长到 51 万美元，到 2033 年达到 140 万美元，在预测期（2026-2033 年）内复合年增长率为 13.4%。

受高通量定序技术进步的推动，全球NGS自动化市场正经历显着成长。与传统方法相比，这些创新技术能够更快、更经济高效地产生DNA和RNA，从而革新基因体学和分子生物学研究。 NGS自动化工作站透过自动化液体处理增强样品製备，确保资料品质的一致性、可靠性和可重复性，同时降低污染风险。这种自动化最大限度地减少了人工干预，提高了NGS工作流程的效率并降低了错误率。药物研发领域的应用以及主要产业参与者提供的多样化产品进一步推动了对自动化的需求成长。然而，高昂的产品成本和召回等挑战可能会阻碍市场扩张。总体而言，当前的市场环境为相关人员提供了动态且不断变化的机会。

全球NGS自动化市场驱动因素

全球NGS自动化市场受多种关键因素驱动，包括对高效自动化下一代次世代定序工作流程的需求日益增长以及癌症发病率的上升。此外，研发投入的增加和医疗费用支出的成长也进一步推动了市场成长。次世代定序技术应用范围的不断扩大以及旨在开发创新样品製备方法的企业合作激增，也促进了市场的显着扩张。预计这些因素将共同塑造NGS自动化产业的未来格局。

限制全球NGS自动化市场的因素

全球新一代定序（NGS）自动化市场面临许多挑战，这些挑战可能会阻碍其成长。主要驱动因素是自动化工作站的高成本。此外，监管障碍和诊断检测缺乏标准化也是限制行业扩张的主要障碍。同时，熟练操作自动化软体所需的专业人员也构成了额外挑战。这些因素共同构成了一个复杂的市场环境，相关人员需要在自动化投资与满足监管和营运要求之间寻求平衡，这可能会限制市场的成长潜力。

全球NGS自动化市场趋势

由于自动化技术的日益普及，全球次世代定序(NGS) 自动化市场正经历显着成长，这些技术能够提升 NGS 工作流程的效率和可靠性。透过简化样品製备流程，自动化不仅提高了资料品质和产量一致性，还提高了生产效率并降低了营运成本。此外，减少人工处理样本和试剂可以最大限度地降低污染风险，从而创造更可靠的研究环境。随着研究人员和实验室不断寻求提高工作流程效率和准确性，对先进 NGS 自动化解决方案的需求预计将持续成长，从而形成一个前景看好的市场。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2023-2025年营收年比比较

主要企业简介

Thermo Fisher Scientific Inc.（USA）
Agilent Technologies, Inc.（USA）
PerkinElmer, Inc.（USA）
Roche Holding AG（Switzerland）
Danaher Corporation（USA）
Tecan Group Ltd.（Switzerland）
Hamilton Company（USA）
Eppendorf AG（Germany）
Hudson Robotics（USA）
10x Genomics, Inc.（USA）
Bio-Rad Laboratories, Inc.（USA）
Illumina, Inc.（USA）
Becton, Dickinson and Company（BD）（USA）
Honeywell International Inc.（USA）
Siemens AG（Germany）
Abbott Laboratories（USA）
LabCorp（Laboratory Corporation of America Holdings）（USA）
Charles River Laboratories International, Inc.（USA）
Brooks Life Sciences（USA）

结论与建议

简介目录

Product Code: SQMIG35A2270

Global NGS Automation Market size was valued at USD 0.45 Million in 2024 and is poised to grow from USD 0.51 Million in 2025 to USD 1.4 Million by 2033, growing at a CAGR of 13.4% during the forecast period (2026-2033).

The global NGS automation market is experiencing significant growth driven by advancements in high-throughput sequencing technologies. These innovations facilitate quicker and more cost-effective generation of DNA and RNA compared to traditional methods, revolutionizing genomics and molecular biology research. NGS automation workstations enhance library preparation through automated liquid handling, ensuring consistent, reliable, and reproducible data quality while reducing contamination risks. This automation minimizes manual intervention, increasing productivity and lowering error rates in the NGS workflow. The rising demand for automation is further propelled by its applications in drug development and a diverse range of offerings from major industry players. However, challenges such as high product costs and recalls may hinder market expansion. Overall, the landscape presents a dynamic and evolving opportunity for stakeholders.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global NGS Automation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global NGS Automation Market Segments Analysis

Global NGS Automation Market is segmented by Product, Application, Sequencing Type, End User and region. Based on Product, the market is segmented into Workstation/Robotic Platform and Reagents & Consumables. Based on Application, the market is segmented into Drug Discovery, Clinical Diagnostics, Oncology, Infectious Diseases, Reproductive Health, Other Clinical Diagnostics and Other Applications. Based on Sequencing Type, the market is segmented into Whole Genome Sequencing, Whole Exome Sequencing, Targeted Genome Sequencing and Others. Based on End User, the market is segmented into Hospitals & Diagnostic Laboratories,Pharmaceuticaland Biotechnology Companies, Academic Research Institutes and Others End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global NGS Automation Market

The Global NGS Automation market is driven by several key factors, including the growing demand for streamlined automation within next-generation sequencing workflows, alongside the increasing incidence of cancer. Additionally, rising investments in research and development, in conjunction with escalating healthcare expenditures, are further propelling market growth. The broadening applications of next-generation sequencing technology, coupled with a surge in collaborations among companies aimed at developing innovative library preparation methods, are also contributing to the market's significant expansion. Together, these elements are set to shape the future landscape of the NGS automation sector.

Restraints in the Global NGS Automation Market

The Global NGS Automation market faces notable challenges that may impede its growth, primarily stemming from the elevated costs associated with automation workstations. Additionally, regulatory hurdles and the lack of standardization in diagnostic testing present significant obstacles to industry expansion. Furthermore, the necessity for a workforce equipped with specialized skills to effectively operate automation software adds another layer of difficulty. These factors collectively contribute to a complex environment that may restrain the market's potential for growth, as stakeholders navigate the balance between investing in automation and addressing regulatory and operational requirements.

Market Trends of the Global NGS Automation Market

The Global NGS Automation market is experiencing significant growth due to the increasing adoption of automation technologies that enhance the efficiency and reliability of next-generation sequencing (NGS) workflows. By streamlining library preparation processes, automation not only improves data quality and yield consistency but also boosts productivity while simultaneously reducing operational costs. Furthermore, the diminished manual handling of samples and reagents minimizes contamination risks, fostering a more reliable research environment. As researchers and laboratories seek to improve workflow efficiency and accuracy, the demand for advanced NGS automation solutions is set to escalate, shaping a promising market landscape.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global NGS Automation Market Size by Product & CAGR (2026-2033)

Market Overview
Workstation/Robotic Platform
Reagents & Consumables

Global NGS Automation Market Size by Application & CAGR (2026-2033)

Market Overview
Drug Discovery
Clinical Diagnostics
Oncology
Infectious Diseases
Reproductive Health
Other Clinical Diagnostics
Other Applications

Global NGS Automation Market Size by Sequencing Type & CAGR (2026-2033)

Market Overview
Whole Genome Sequencing
Whole Exome Sequencing
Targeted Genome Sequencing
Others

Global NGS Automation Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals & Diagnostic Laboratories
Pharmaceutical and Biotechnology Companies
Academic Research Institutes
Others End Users

Global NGS Automation Market Size & CAGR (2026-2033)

North America (Product, Application, Sequencing Type, End User)
- US
- Canada
Europe (Product, Application, Sequencing Type, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Application, Sequencing Type, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Application, Sequencing Type, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Application, Sequencing Type, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Thermo Fisher Scientific Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Holding AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tecan Group Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hamilton Company (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eppendorf AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hudson Robotics (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
10x Genomics, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Illumina, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (BD) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Honeywell International Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LabCorp (Laboratory Corporation of America Holdings) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Charles River Laboratories International, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Brooks Life Sciences (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments